Press Releases

With Novartis joining the suprachoroidal race with their novel injector and Genentech's re-designed sustained release formulations showing promise for wet AMD, there has never been a…
Read More...

The three-day agenda for the 6th Chronic Kidney Disease (CKD) Drug development Summit has been announced. Taking place March 19-21, 2024 in Boston, M.A., this year’s program features…
Read More...

Taking place during the 14th World ADC San Diego, the 10th World ADC Awards reunited both newcomers and leaders of the antibody-drug conjugate industry this October 18, 2023.…
Read More...

See full summit details here. Over the past year, the allogeneic cell therapy landscape has continued to evolve. Amidst the clinical and commercial developments, the challenging…
Read More...

This ground-breaking event is tailor-made for scientists, analytical and research and development professionals within the pharmaceutical, biopharmaceuticals, natural products,…
Read More...

"The conference is the place to be for the E&L community!" - Senior Business Development Manager, Agilent Technologies Now in its 17th year, E&L Europe is set to take place…
Read More...

E&L examination is continuously growing in importance and given the current scrutiny paid by governing bodies including the FDA and MHRA, understanding the best practice and…
Read More...

Now in its 17th year, E&L Europe is set to take place on 6-7 November in Amsterdam and once again will feature leading industry experts covering the most pertinent topics impacting…
Read More...

See the full summit details here. The 7th IPF Summit, a premier event in the field of pulmonary fibrosis research, is set to take place from September 19 to 21, 2023, in the vibrant…
Read More...

Are you ready to embark on a transformative journey in the world of chromatography purification? Look no further than PURIFY'23 – the most anticipated event of the year for…
Read More...

Pressing issues around care affordability and access threaten US insurance models. We must shift our focus to examining the latest research on the links between out-of-pocket spending…
Read More...

Given the resurgence of investment and investigation into oligonucleotides, the Oligonucleotide CMC & Analytical Development team did an exclusive interview with leading industry…
Read More...

The oligonucleotide field is ever evolving at a rapid pace, as experts continue to optimize manufacturing processes, develop robust analytical methods, and ensure the quality and safety…
Read More...

The oligonucleotide industry needs collaboration between biopharma and regulatory experts to optimize manufacturing processes, develop robust analytical methods, and ensure the quality…
Read More...

Our health system exists to allow all people to fulfill their human potential. Now, the challenge of undoing a legacy of systemic disparities falls on a our shoulders as we continue to…
Read More...

Fixing our broken system demands we connect disparate data, streamline clinical workflows, and zero in on consumer orientated, digitally enabled care delivery. Yet just how much…
Read More...

The good news continues as BioAtla Announces FDA Clearance of Investigational New Drug Application for BA3182, a CAB-EpCAMxCAB-CD3 Bispecific T-Cell Engager for the Treatment of…
Read More...

With only 5 weeks to go, the 80+ attendee list for the upcoming mRNA Process Development and Manufacturing Summit Europe (April 18th – 20th | Frankfurt, Germany) is still growing fast,…
Read More...

Healthcare continues to face crippling staff shortages, while communities are left underserved, and the national mental health crisis persists. Providers are battling to meet…
Read More...

Over the last few decades, immunotherapy has developed at a rapid rate in the treatment of cancer where neoantigens are the lates breakthrough in tumour immunotherapy. Today, it is…
Read More...